Zhao J, Zhao F, Shi Y, Deng Y, Hu X, Shen H. The efficacy of a new high intensity focused ultrasound therapy for locally advanced pancreatic cancer. J Cancer Res Clin Oncol. 2017;143(10):2105–11.
Siu JY, Liu C, Zhou Y. High-intensity focused ultrasound ablation around the tubing. PLoS One. 2017;12(11):e0188206.
Maloney E, Hwang JH. Int J Hyperthermia. 2015; 31(3):302–309.
Feng G, Hao L, Xu C, Ran H, Zheng Y, Li P, Cao Y, Wang Q, Xia J, Wang Z. Int J Nanomedicine. 2017; 28(12):4647–4659.
Xiaoping L, Leizhen Z. Advances of high intensity focused ultrasound (HIFU) for pancreatic cancer. Int J Hyperth. 2013;29(7):678–82.
Wu CC, Chen WS, Ho MC, Huang KW, Chen CN, Yen JY, Lee PH. Minimizing abdominal wall damage during high-intensity focused ultrasound ablation by inducing artificial ascites. J Acoust Soc Am. 2008;124(1):674–9.
Facy O, Al Samman S, Magnin G, Ghiringhelli F, Ladoire S, Chauffert B, Rat P, Ortega-Deballon P. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study. Ann Surg. 2012;256(6):1084–8.
Mikolajczyk A, Khosrawipour V, Kulas J, Kocielek K, Migdal P, Arafkas M, Khosrawipour T. Release of doxorubicin from its liposomal coating via high intensity ultrasound. Mol Clin Oncol. 2019;11(5):483–7.
Mikolajczyk A, Khosrawipour V, Schubert J, Grzesiak J, Chaudhry H, Pigazzi A, Khosrawipour T. Effect of Liposomal Doxorubicin in Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC). J Cancer. 2018;9(23):4301–5.
Santos MA, Goertz DE und Hynynen K. Focused ultrasound hyperthermia mediated drug delivery using Thermosensitive liposomes and visualized with in vivo two-photon microscopy. Theranostics. 2017; 7(10):2718–2731.
Huang L, Zhou K, Zhang J, Ma Y, Yang W, Ran L, Jin C, Dimitrov DD, Zhu H. Efficacy and safety of high-intensity focused ultrasound ablation for hepatocellular carcinoma by changing the acoustic environment: microbubble contrast agent (SonoVue) and transcatheter arterial chemoembolization. Int J Hyperth. 2019;36(1):244–52.
Daecher A, Stanczak M, Liu JB, Zhang J, Du S, Forsberg F, Leeper DB, Eisenbrey JR. Localized microbubble cavitation-based antivascular therapy for improving HCC treatment response to radiotherapy. Cancer Lett. 2017;28(411):100–5.
Strunk HM, Lützow C, Henseler J, Mücke M, Rauch M, Marx C, Schild HH, Marinova M. Mesenteric vessel patency following HIFU therapy in patients with locally invasive pancreatic Cancer. Ultraschall Med. 2018;39(6):650–8.
Jain RK. Barriers to drug delivery in solid tumors. Sci Am. 1994;271:58–65.
Khosrawipour V, Mikolajczyk A, Schubert J, Khosrawipour T. Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) via Endoscopical Microcatheter System. Anticancer Res. 2018;38(6):3447–52.
Khosrawipour T, Wu D, Bellendorf A, Mohanaraja KE, Diaz-Carballo D, Khosrawipour V. Feasibility of Single Tumorspot treatment in Peritoneal Carcinomatosisi via Close range Doxorubicin impaction in Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC). J Clin Exp Oncol. 2017;6:3.
Khosrawipour V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D, Förster E, Osma A, Adamietz IA, Zieren J, Fakhrian K. Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model. Anticancer Res. 2016;36(9):4595–600.
Khosrawipour V, Diaz-Carballo D, Acikelli AH, Khosrawipour T, Falkenstein TA, Wu D, Zieren J, Giger-Pabst U. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on in vitro proliferation of human colonic cancer cells. World J Surg Oncol. 2016;15(1):94.
Schubert J, Khosrawipour V, Chaudhry H, Arafkas M, Knoefel WT, Pigazzi A, Khosrawipour T. Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC). World J Surg Oncol. 2019;17(1):93.
Khosrawipour V, Giger-Pabst U, Khosrawipour T, Pour YH, Diaz-Carballo D, Förster E, Böse-Ribeiro H, Adamietz IA, Zieren J, Fakhrian K. Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model. J Cancer. 2016;7(8):910–4.
Khosrawipour V, Khosrawipour T, Hedayat-Pour Y, Diaz-Carballo D, Bellendorf A, Böse-Ribeiro H, Mücke R, Mohanaraja N, Adamietz IA, Fakhrian K. Effect of Whole-abdominal Irradiation on Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in a Post-mortem Swine Model. Anticancer Res. 2017;37(4):1677–80.
Khosrawipour V, Bellendorf A, Khosrawipour C, Hedayat-Pour Y, Diaz-Carballo D, Förster E, Mücke R, Kabakci B, Adamietz IA, Fakhrian K. Irradiation Does Not Increase the Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model. In Vivo. 2016;30(5):593–7.
Lyon PC, Griffins LF, Lee J, Chung D, Carlise R, Wu F, Middelton MR, Gleeson FV, Coussios CC. Clinical trial protocol for Tardox: a phase I study to investigate the feasibility of target release of lyso-thermosensitive liposomal doxorubicin (ThermoDox) using focused ultrasound in patients with liver tumors. J Ther Ultrasound. 2017;5:28.
Khosrawipour V, Reinhard S, Martino A, Khosrawipour T, Arafkas M, Mikolajczyk A. Increased Tissue Penetration of Doxorubicin in Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) after High-Intensity Ultrasound (HIUS). Int J Surg Oncol. 2019;2019:6185313.
Kastelein AW, Vos LMC, van Baal JOAM, Koning JJ, Hira VVV, Nieuwland R, van Driel WJ, Uz Z, van Gulik TM, van Rheenen J, Ince C, Roovers JWR, van Noorden CJF, Lok CAR. Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer. Clin Exp Metastasis. 2020. https://doi.org/10.1007/s10585-020-10024-4 [Epub ahead of print].
Ning Z, Zhu Z, Wang H, Zhang C, Xu L, Zhuang L, Yan X, Wang D, Wang P, Meng Z. High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells. Onco Targets Ther. 2019;12(12):1161–70.